Can Healthcare Reform Live Up to the Hype?

National Healthcare legislation has created a contentious debate about the best way to deliver care while lowering costs and increasing access. Legislation that passed through Congress calls for nearly $1 trillion to overhaul the health insurance industry. What does this mean for companies providing health solutions to doctors and patients? Will new regulations inhibit patient options? What impact will this have on innovation and product development strategies? What is the expectation from those behind the legislation of where it will take this industry?

Panelists:

Imran Nasrullah - Chief Business Officer, MassBio (Moderator)

Tom Dehner - Former Director, Massachusetts Medicaid Director & Board Member, Health Connector

Eric Elliott - President, CIGNA Pharmacy

Randel Richner - Founder and President, Neocure

Special Thanks to: